Interim Results | List of Frontiers open access articles

Original Research

Published on 17 Jun 2021

Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial

in Alloimmunity and Transplantation

Ye Zhao
Xuewei Li
Yujing Zhou
Jin Gao
Yang Jiao
Baoli Zhu
Depei Wu
Xiaofei Qi

Frontiers in Immunology

doi 10.3389/fimmu.2021.678476

11,407 views
70 citations

Original Research

Published on 23 Aug 2017

Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations

in Neuroprosthetics

Katarina Stingl
Ruth Schippert
Karl U. Bartz-Schmidt
Dorothea Besch
Charles L. Cottriall
Thomas L. Edwards
Florian Gekeler
Udo Greppmaier
Katja Kiel
Assen Koitschev

Frontiers in Neuroscience

doi 10.3389/fnins.2017.00445

17,183 views
191 citations

Brief Research Report

Published on 17 Oct 2023

Cost comparison of in-person and telehealth modalities for a suicide safety planning group intervention: interim results from the “Project Life Force” randomized clinical trial

in Public Mental Health

Rebecca A. Raciborski
Kyra K. Hamerling-Potts
Emily L. Mitchell
Sarah R. Sullivan
Nidhi Kapil-Pair
Sara J. Landes
Shari Jager-Hyman
Marianne Goodman

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1215247

3,370 views

Original Research

Published on 01 Nov 2022

Workplace factors can predict the stress levels of healthcare workers during the COVID-19 pandemic: First interim results of a multicenter follow-up study

in Occupational Health and Safety

Na-na Xiong
Teng-teng Fan
Rainer Leonhart
Kurt Fritzsche
Qi Liu
Lei Luo
Barbara Stein
Christiane Waller
Mingjin Huang
Markus M. Müller

Frontiers in Public Health

doi 10.3389/fpubh.2022.1002927

3,898 views
10 citations

Original Research

Published on 05 Jan 2026

Toward a PSMA PET–mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial

in Genitourinary Oncology

Monica Celli
Roberta Gunelli
Fabio Ferroni
Matteo Costantini
Domenico Barone
Lorenzo Fantini
Eugenia Fragalà
Irene Marini
Valentina Di Iorio
Flavia Foca

Frontiers in Oncology

doi 10.3389/fonc.2025.1720861

897 views

Original Research

Accepted on 25 Feb 2026

Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial

in Surgical Oncology

Joris Vangeneugden
Saar Vermijs
Peter De Kuyper
Camille Berquin
Nicolaas Lumen
Victor Declerck
Frederic Baekelandt
Christophe Ghysel
Yannic Raskin
Bernard Bynens

Frontiers in Oncology

Original Research

Published on 16 Jun 2025

A novel and safe SmartCap® SC101 to develop the COVID-19 mRNA vaccine STP2104 inducing potent immune responses in humans

in Vaccines and Molecular Therapeutics

Rachel Kim
Tae-Gi Uhm
Jisu Kim
Dayeon Woo
Uk-Il Kim
Xue Meng
Byounggu Yang
Suhyeon Kim
Heejene Kim
Jonghyeon Kim

Frontiers in Immunology

doi 10.3389/fimmu.2025.1571092

3,893 views

Review

Published on 22 Jul 2021

TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer

in Cancer Immunity and Immunotherapy

Zhouhong Ge
Maikel P. Peppelenbosch
Dave Sprengers
Jaap Kwekkeboom

Frontiers in Immunology

doi 10.3389/fimmu.2021.699895

63,086 views
210 citations

Original Research

Published on 16 Mar 2017

East Indian Sandalwood Oil (EISO) Alleviates Inflammatory and Proliferative Pathologies of Psoriasis

in Ethnopharmacology

Manju Sharma
Corey Levenson
Ian Clements
Paul Castella
Kurt Gebauer
Michael E. Cox

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00125

19,209 views
39 citations

Clinical Trial

Published on 31 May 2019

The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial

in Cancer Immunity and Immunotherapy

Donald T. Weed
Serena Zilio
Isildinha M. Reis
Zoukaa Sargi
Marianne Abouyared
Carmen R. Gomez-Fernandez
Francisco J. Civantos
Carla P. Rodriguez
Paolo Serafini

Frontiers in Immunology

doi 10.3389/fimmu.2019.01206

13,778 views
57 citations

Clinical Trial

Published on 17 Jan 2024

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

in Neuromuscular Disorders and Peripheral Neuropathies

James F. Howard
Vera Bril
Tuan Vu
Chafic Karam
Stojan Peric
Jan L. De Bleecker
Hiroyuki Murai
Andreas Meisel
Said R. Beydoun
Mamatha Pasnoor

Frontiers in Neurology

doi 10.3389/fneur.2023.1284444

35,928 views
59 citations

Original Research

Published on 30 Sep 2022

Patient demographics and characteristics from an ambispective, observational study of patients with duchenne muscular dystrophy in Saudi Arabia

in Pediatric Neurology

Abdulaziz S. AlSaman
Fouad Al Ghamdi
Ahmed K. Bamaga
Nahla AlShaikh
Mohammed Al Muqbil
Osama Muthaffar
Fahad A. Bashiri
Baleegh Ali
Arzu Mulayim
Elena Heider

Frontiers in Pediatrics

doi 10.3389/fped.2022.1020059

6,934 views
5 citations

Systematic Review

Published on 15 Oct 2021

Novel Androgen Receptor Inhibitors in Non-Metastatic, Castration-Resistant Prostate Cancer: A Systematic Review and Network Meta-Analysis

in Genitourinary Oncology

Yelin Mulati
Yu Fan
Wei Yu
Qian Zhang
Zhisong He

Frontiers in Oncology

doi 10.3389/fonc.2021.733202

7,343 views
12 citations

Original Research

Published on 20 May 2021

Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome

in Epilepsy

Luigi Francesco Iannone
Gabriele Arena
Domenica Battaglia
Francesca Bisulli
Paolo Bonanni
Antonella Boni
Maria Paola Canevini
Gaetano Cantalupo
Elisabetta Cesaroni
Manuela Contin

Frontiers in Neurology

doi 10.3389/fneur.2021.673135

9,186 views
43 citations

Clinical Trial

Published on 09 Jun 2022

Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical Trial

in Cardiovascular Therapeutics

Carolina T. Macedo
Ticiana F. Larocca
Márcia Noya-Rabelo
Roque Aras
Cristiano R. B. Macedo
Moisés I. Moreira
Alessandra C. Caldas
Jorge A. Torreão
Victor M. A. Monsão
Clarissa L. M. Souza

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.864837

2,761 views
3 citations

Articles

Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial

Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations

Cost comparison of in-person and telehealth modalities for a suicide safety planning group intervention: interim results from the “Project Life Force” randomized clinical trial

Workplace factors can predict the stress levels of healthcare workers during the COVID-19 pandemic: First interim results of a multicenter follow-up study

Toward a PSMA PET–mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial

Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial

A novel and safe SmartCap® SC101 to develop the COVID-19 mRNA vaccine STP2104 inducing potent immune responses in humans

TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer

East Indian Sandalwood Oil (EISO) Alleviates Inflammatory and Proliferative Pathologies of Psoriasis

The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

Patient demographics and characteristics from an ambispective, observational study of patients with duchenne muscular dystrophy in Saudi Arabia

Novel Androgen Receptor Inhibitors in Non-Metastatic, Castration-Resistant Prostate Cancer: A Systematic Review and Network Meta-Analysis

Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome

Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical Trial